Amphion signs partnership agreement with Kuwait University

Published December 6th, 2009 - 03:31 GMT
Amphion Innovations plc (LSE: AMP) (“Amphion”), the developer of medical and technology businesses, today announces that it has signed a partnership agreement with Kuwait University (KU), the State’s first and oldest University established  in the year 1966, for academic and research advancement.  This Agreement is aimed at establishing and operating a Technology Transfer Unit (TTU) at KU. This facility will be the first in-house TTU in Kuwait.
Amphion will focus on supporting decision making within the TTU on IP protection. This will include patenting as well as analysing the IP's technical and market value with the key aim of enabling strategic decision making about what, if any, commercialisation efforts are appropriate.  Normally, this commercialisation would take place via licensing, but sometimes it may lead to the creation of a new company.  Amphion has already been active for many years in commercialising IP in a number of universities in Europe and the US.
Amphion has an established presence in the region, both through its Partner Company Motif BioSciences and its investor base, which includes members of prominent Gulf families.  Motif has been active in the region for over 5 years and has on-going projects looking at the genetic patterns behind major diseases relevant to populations in the Gulf, including diabetes, obesity and some types of cancer.
Richard Morgan, CEO of Amphion, said:
“As the range of research outputs from Kuwait University continues to grow in scope and international recognition, establishing effective technology transfer functions becomes increasingly important.  Amphion Innovations is excited to be working alongside Prof. Fahed Al-Thaqeb, the Vice President for Research, and Research Administration at Kuwait University in establishing this Technology Transfer Unit and we look forward to announcing further developments in the future.”

© 2000 - 2019 Al Bawaba (

You may also like